FDA Takes Caution on Approving New Drugs
August 18, 2007 By LINDA A. JOHNSON, AP Business Writer
Graphic shows Food and Drug Administration drug approvals through July
(AP) -- Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
FDA: 'limited' benefit with tamper-proof OxyContin
Sep 22, 2009 |
not rated yet |
0
Food and drug agency to study greater openness
Jun 02, 2009 |
not rated yet |
1
FDA probes liver damage with weight loss pill alli
Aug 24, 2009 |
not rated yet |
0
FDA approves new drug for deadly kidney cancer
Mar 30, 2009 |
not rated yet |
0
GAO: FDA yet to make safety changes post-Vioxx
Dec 09, 2009 |
not rated yet |
0
2 hours ago
